Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Current Treatment approach to a mild to moderate atopic dermatitis patient.
For patients with mild to moderate atopic dermatitis, the primary treatment approach focuses on moisturizing the skin. Regular use of emollients helps to restore the skin barrier, reducing dryness and irritation. Patients are encouraged to apply these moisturizers multiple times a day, especially after bathing.
Topical corticosteroids are commonly prescribed to manage inflammation and itching. These medications come in various strengths, allowing healthcare providers to tailor treatment based on the severity of the symptoms. Patients should apply the corticosteroids as directed, typically once or twice daily, for the best results.
In addition to corticosteroids, calcineurin inhibitors like tacrolimus or pimecrolimus can be used as an alternative treatment. These medications help reduce inflammation without the side effects associated with long-term steroid use. They are particularly useful for sensitive areas, such as the face and neck.
Therefore, get an overall knowledge of the current Treatment approach to a mild to moderate atopic dermatitis patient. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Survival rates for incurable larynx cancer investigated for first time
2.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
3.
Knowing about and avoiding bladder cancer.
4.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
5.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
1.
Evidence-Based Approaches in Hematology for Modern Medicine
2.
Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery
3.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
4.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation